AmJCardiovascDrug

Cost-ConsequenceAnalysisofUsingCangrelorinHighAngiographicRiskPercutaneousCoronaryInterventionPatients:AUSHospitalPerspective-AmericanJournalofCardiovascularDrugsAmJCardiovascDrugsOriginalResearchArticleEarlyRecent,July31,./s---9本文由“天纳”临床学术信息人工智能系统自动翻译点击文末“阅读原文”下载本文PDFObjectivesTheobjectiveofthisstudywastoevaluateaUShospital’scostimplicationsandout

转载请注明：http://www.zhuanjiz.com/gbby/8478.html

• 上一篇文章： 打通胸痛卒中救治的起跑ldquo第
  
• 下一篇文章： 脓毒病心肌病研究进展